Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycogen phosphorylase is a key enzyme in carbohydrate metabolism, catalyzing the rate-limiting step of glycogenolysis—the breakdown of glycogen into glucose-1-phosphate. It exists in multiple isoforms (muscle, liver, brain) with distinct regulatory properties. Regulation occurs through allosteric effectors and covalent modification (phosphorylation/dephosphorylation). It is a therapeutic target for metabolic diseases like type II diabetes.
Inhibition of glycogen breakdown
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycogen Phosphorylase (GP).